Vigor Medical Technologies develops and will commercialise life saving innovative devices for treatment of chest trauma.
Vigor Medical Technologies Ltd. develops and will commercialise life saving innovative devices for treatment of chest trauma and for thoracic/abdominal drainage. According to World Health Organization (WTO) over 4 Million cases of chest trauma occure worldwide annually and it is the leading cause of accidental death. Vigor's self-fixation sealing devices prevent lung and heart collapse, both of which are fatal if not immediately identified, treated and reassessed for effective management in the hospital.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 19, 2022 | Grant | — | 1 | European Innovation Council | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Innovation Council | Yes | Grant |